Irregularities in imported medicine? DRI conducted searches at Cipla's Mumbai office and Bhiwandi warehouse; here is the update.
The Directorate of Revenue Intelligence (DRI) conducted searches at Cipla's Mumbai office and Bhiwandi warehouse in a case related to the classification of imported medicine. The company cooperated and stated that this action did not have any significant impact on operations, although a decline in shares was recorded.
Explanation in simple terms
- What:
- Tax investigators searched company offices and a warehouse regarding how medicines were categorized for import.
- Who:
- The Directorate of Revenue Intelligence is the investigating agency and Cipla Limited is the company being investigated.
- When:
- Reported on 17 Nov 2026.
- Where:
- Mumbai and Bhiwandi, Maharashtra.
- Why:
- The search relates to the classification of imported medicine.
- What it means:
- The company is cooperating with the investigation and reports no major impact on its daily business operations.





Discussion
No comments yet.
Follow this case to join the discussion.